On July 19, 2022, BioWorldfeatured insights from AFAR Scientific Director Nir Barzilai, MD, on the use of therapeutic interventions to expand healthspan and increase lifespan. Dr. Barzilai noted the upcoming AFAR-managed TAME Trials as an opportunity to research to benefits of one therapeutic, metformin.
In addition to serving as AFAR’s Scientific Director, Dr. Barzilai is a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award of Distinction recipient, and the Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.
Read the article, “For Preventing Aging, Some Decades Old Drugs?” here.
Learn more about the TAME Trial here.
